sumatriptan has been researched along with Adverse Drug Event in 13 studies
Sumatriptan: A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.
sumatriptan : A sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). Used (in the form of its succinate salt) for the acute treatment of migraine with or without aura in adults.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The management of cluster headache is similar to that of other primary headache disorders and can be broadly divided into acute and preventive treatments." | 3.01 | Management of cluster headache: Treatments and their mechanisms. ( Burish, MJ; Peng, KP, 2023) |
| " Safety was evaluated based on the frequency of reported adverse events, and treatment with eASA was associated with lower incidence of adverse events than was with sumatriptan." | 2.44 | Efficacy and safety of 1,000 mg effervescent aspirin: individual patient data meta-analysis of three trials in migraine headache and migraine accompanying symptoms. ( Diener, HC; Lampl, C; Voelker, M, 2007) |
| "We aimed at evaluating adverse drug reactions during the post-marketing phase with erenumab as the suspected/interacting drug in Eudravigilance, with the final goal of investigating the consistency of the disproportionality signals (DS) for erenumab in Eudravigilance and the American Food and Drug Administration Adverse Event Reporting System (FDA FAERS) and undetected DS from Eudravigilance." | 1.72 | Post-marketing safety surveillance of erenumab: new insight from Eudravigilance. ( Liang, D; Sessa, M, 2022) |
| "5 million adverse drug reaction (ADR) reports for 8620 drugs/biologics that are listed for 1191 Coding Symbols for Thesaurus of Adverse Reaction (COSTAR) terms of adverse effects." | 1.32 | Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. ( Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL, 2004) |
| "To determine the level of concern among migraineurs about migraine prescription medication tolerability and adverse effects and the impact of these concerns on their self-management of migraine." | 1.32 | Migraine medication attributes important for patient compliance: concerns about side effects may delay treatment. ( Gallagher, RM; Kunkel, R, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Matthews, EJ | 1 |
| Kruhlak, NL | 1 |
| Weaver, JL | 1 |
| Benz, RD | 1 |
| Contrera, JF | 1 |
| Liu, Z | 1 |
| Shi, Q | 1 |
| Ding, D | 1 |
| Kelly, R | 1 |
| Fang, H | 1 |
| Tong, W | 1 |
| Morgan, RE | 1 |
| van Staden, CJ | 1 |
| Chen, Y | 1 |
| Kalyanaraman, N | 1 |
| Kalanzi, J | 1 |
| Dunn, RT | 1 |
| Afshari, CA | 1 |
| Hamadeh, HK | 1 |
| Liang, D | 1 |
| Sessa, M | 1 |
| Peng, KP | 1 |
| Burish, MJ | 1 |
| Aschenbrenner, DS | 1 |
| Dodick, DW | 1 |
| Gallagher, RM | 1 |
| Kunkel, R | 1 |
| Flaten, O | 1 |
| Lampl, C | 1 |
| Voelker, M | 1 |
| Diener, HC | 1 |
| Offerhaus, L | 1 |
| Nightingale, SL | 1 |
2 reviews available for sumatriptan and Adverse Drug Event
| Article | Year |
|---|---|
Management of cluster headache: Treatments and their mechanisms.
Topics: Autonomic Nervous System; Cluster Headache; Drug-Related Side Effects and Adverse Reactions; Humans; | 2023 |
Efficacy and safety of 1,000 mg effervescent aspirin: individual patient data meta-analysis of three trials in migraine headache and migraine accompanying symptoms.
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dose-Response Relatio | 2007 |
11 other studies available for sumatriptan and Adverse Drug Event
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Dru | 2004 |
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Da | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily | 2013 |
Post-marketing safety surveillance of erenumab: new insight from Eudravigilance.
Topics: Adverse Drug Reaction Reporting Systems; Antibodies, Monoclonal, Humanized; Databases, Factual; Drug | 2022 |
Sumatriptan Patch is Temporarily Suspended.
Topics: Administration, Cutaneous; Burns; Drug-Related Side Effects and Adverse Reactions; Humans; Migraine | 2016 |
CASE 1: the well-intentioned triptan prescriber.
Topics: Cluster Headache; Drug-Related Side Effects and Adverse Reactions; Humans; Male; Malpractice; Middle | 2008 |
Migraine medication attributes important for patient compliance: concerns about side effects may delay treatment.
Topics: Adolescent; Adult; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Drug Therapy; Drug-Related S | 2003 |
[Are children getting the right drugs?].
Topics: Analgesics, Opioid; Anesthetics, Intravenous; Child; Clinical Trials as Topic; Drug Industry; Drug-R | 2006 |
[Foreign reports on side effects of drugs].
Topics: Australia; Drug-Related Side Effects and Adverse Reactions; Humans; Indoles; Ranitidine; Sulfonamide | 1993 |
From the Food and Drug Administration.
Topics: Cholesterol; Consumer Product Safety; Drug-Related Side Effects and Adverse Reactions; Equipment and | 1993 |
[2,700 reported adverse effects of drugs in 1991. A large spectrum of new antidepressive agents].
Topics: Adult; Antidepressive Agents; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Indol | 1992 |